Pictet Group

Disclosure - Trading strategy publications

Important information

Trading Strategy publicaitons are reserved for the exclusive use of the recipients to whom they are addressed. They are are also intended for distribution to professional clients, accredited investors, expert investors and institutional investors only, and not to retail investors. Please see important disclosure and disclaimer information below.

General disclaimer

This document is distributed by the Trading Strategy team in the trading department of Bank Pictet & Cie (Asia) Ltd ("BPCAL") in Singapore


This document is only meant as a marketing tool and is not a product of any independent financial research unit. The information, tools and material presented in this document are provided for information purposes only and are not to be used or considered as an offer, an invitation to offer or solicitation to buy, sell or subscribe for any securities, commodities, derivatives, (in respect of Singapore only) futures, or other financial instruments (collectively referred to as “Investments”) or to enter into any legal relations, nor as advice or recommendation with respect to any Investments.

This document contains a series of trading tips. The model portfolio set out in this document is not a portfolio management product, it may not be updated and BPCAL may discontinue the publication of the model portfolio at any time. An investor should not replicate part or all of, or rely on the model portfolio to construct its own investment portfolio.
This document is intended for general circulation and does not have regard to the specific investment objectives, financial situation and/or the particular needs of any recipient of this document. Investors should seek independent financial advice regarding the appropriateness of investing in any Investments or adopting any strategies discussed in this document, taking into account the specific investment objectives, financial situation or particular needs of the investor, before making a commitment to invest.

BPCAL has not taken any steps to ensure that the Investments referred to in this document are suitable for any particular investor, and accepts no fiduciary duties to any investor in this regard. Furthermore, BPCAL makes no representations and gives no advice concerning the appropriate accounting treatment or possible tax consequences of any Investment. Any investor interested in buying or making any Investment should conduct its own investigation and analysis of the Investment and consult with its own professional adviser(s) as to any Investment including the risks involved with transactions on such Investment.

This document is not to be relied upon in substitution for the exercise of independent judgment. The value and income of any Investment mentioned in this document may fall as well rise. The market value may be affected by, amongst other things, changes in economic, financial, political factors, time to maturity, market conditions and volatility, and the credit quality of any issuer or reference issuer. Furthermore, foreign currency rates of exchange may have a positive or adverse effect on the value, price or income of any Investment mentioned in this document.  Accordingly, investors must be willing and able to, and effectively assume all risks and may receive back less than originally invested.

Past performance should not be taken as an indication or guarantee of future performance and no representation or warranty, expressed or implied, is made by BPCAL regarding future performance.

The information presented herein is mostly based on data and information which are available publicly including technical analysis elements. In researching the historical prices and trading volume of Investments, the analysts who prepared this document applied technical methods and formulas to identify price trends. This document does not constitute the investment policy of BPCAL, or an investment recommendation, and merely contains the different assumptions, views and analytical methods of the analysts who prepared them. Furthermore, the information (including without limitation the model portfolio), opinions and estimates set out or expressed herein reflect the technical analysis at its original date of publication and are subject to change without notice and without any obligation on BPCAL to maintain, update or amend any of them, or notify an investor in the event that such information, opinions or estimates become incorrect or inaccurate.  BPCAL may have issued or distributed other reports or documents that are inconsistent with, and reach different conclusions from, the information presented in this document.

While the information and opinions presented herein are believed to be from sources believed to be reliable, BPCAL is not able to, and do not make any representation or warranty as to its accuracy or completeness. The information presented herein which are from a specific source is quoted in this document where relevant. Otherwise, such information may have been gathered from dissemination services which are available to the public e.g. Bloomberg, Reuters etc. Accordingly, BPCAL accepts no liability for loss arising from the use of or reliance on this document presented for information purposes only. BPCAL reserves the right to act upon or use any of the information in this document at any time, including before its publication herein.

The information used to prepare this document and/or any part of such information, may have been provided or circulated to employees and/or one or more clients of BPCAL before this document was received by you and such information may have been acted upon by such recipients or by BPCAL.

This document is provided solely for the information of the intended recipient only and should not be reproduced, published, circulated or disclosed in whole or in part to any other person without the prior written consent of BPCAL.

Conflict of Interest

A part of the compensation of the analysts may be, directly or indirectly, related to the specific performance of recommendations or views expressed in this report. Analysts are also paid a salary plus bonus based on the overall revenue generated by the Pictet Group which may include a portion of which is generated by the trading department. In addition, the analysts who have prepared this document have not received compensation from any company mentioned in this report in the last 12 months.

In respect of the companies mentioned in this report: (a) BPCAL and/or its employees (including the analysts who prepared this document) may from time to time have long or short positions or holdings in the securities or other related investments, (b) BPCAL may use the above mentioned strategy for its proprietary activity or (c) the analysts responsible for this document and any of their immediate family members are not officers, directors or advisory board members of any company mentioned in this document.

BPCAL and its analysts adhere to professional standards and abide by formal code of ethics that put interests of clients ahead of their own. BPCAL or any of its affiliates have not, in respect of any company mentioned in this document: (a) managed or co-managed a public offering in the past 12 months, (b) received any compensation for investment banking services in the past 12 months, (c) received or expect or receive, or intend to seek compensation for investment banking services in the next three months and (d) participated in any issues of securities in the last three years.

BPCAL or any of its affiliates are not able to exclude, in respect of any company mentioned in this document, having holdings in one or more classes of common equity securities in that company. BPCAL and its affiliates provide a vast array of financial services other than investment banking services to a large number of corporations globally. The investor should assume that BPCAL and its affiliates receive compensation for those services from such corporations. The sales and trading department of BPCAL may be engaged in selling and trading in securities in the companies mentioned in this document. BPCAL or its affiliates may from time to time act as a market maker for any Investments mentioned in this document.

Singapore

This document is not directed to, or intended for distribution, publication to or use by, persons who are not accredited investors, expert investors or institutional investors as defined in section 4A of the Securities and Futures Act (Cap. 289 of Singapore) (“SFA”) or any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation or would subject Bank Pictet & Cie (Asia) Ltd ("BPCAL“) and any of its affiliates or related corporations to any prospectus or registration requirements.

BPCAL has obtained an exemption from the Monetary Authority of Singapore (“MAS”) under section 100(2) of the Financial Advisers Act (“FAA”) for the provision of financial advisory services to High Net Worth Individuals (as defined in the MAS Guidelines on Exemption for Specialised Units Serving High Net Worth Individuals FAA-G07) (the “Exemption”) and is exempted from the requirements of sections 25, 27, 28 and 36 of the FAA, the MAS Notice on Recommendations on Investment Products (FAA-N16), MAS Notice on Appointment and Use of Introducers by Financial Advisers (FAA-N02), MAS Notice on Information to Clients and Product Information Disclosure (FAA-N03) and MAS Notice on Minimum Entry and Examination Requirements for Representatives of Licensed Financial Advisers and Exempt Financial Advisers (FAA-N13).

Hong Kong

This document is not directed to, or intended for distribution, publication to or use by, persons in Hong Kong, other than (a) to or by “professional investors” within the meaning of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) and any rules made thereunder (the “SFO”) or (b) in other circumstances which do not result in the document being a “prospectus” as defined in the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32 of the Laws of Hong Kong) or which do not constitute an offer to the public within the meaning of that Ordinance.
BPCAL does not carry on any banking business in Hong Kong.  It is not an authorized institution within the meaning of the Banking Ordinance (Cap. 155 of the Laws of Hong Kong) or subject to the supervision of the Hong Kong Monetary Authority.

Warning: The contents of this document have not been reviewed by any regulatory authority in Hong Kong.  You are advised to exercise caution.  If you are in any doubt about any of the contents of this document, you should obtain independent professional advice.

United States

In the United States, distribution by BPCAL is permitted as provided by the exemption under article 15a-6 of the Securities Exchange Act of 1934, and is is intended exclusively for major US institutional investors, as defined by article 15a-6 of the Securities Exchange Act. All major US institutional investors wishing to carry out a transaction may only do so by contacting a US registered broker-dealer, such as Pictet Overseas Inc.: 1000 de la Gauchetière West, Suite 3100, Montreal, QC, Canada.  Tel: 514-288-8161, Fax: 514-288-5472.

United Kingdom

This document is made available to persons who are investment professionals as that term is defined in Article 19 of the Financial Services and Markets Act 2000 (Financial Promotion Order) 2005 and is intended solely for the addressee(s). [This document is made available to persons who are investment professionals as that term is defined by law and is intended solely for the addressee(s).]

European Economic Area (“EEA”) outside the UK

This document is intended only for EEA institutional clients or others to whom it may lawfully be submitted.

Rest of the world

This document is not directed at, or intended for distribution to or use by, any person or entity (i) who is a citizen or resident of, or located in, any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation or (ii) where such distribution, publication, availability or use would be contrary to applicable law or would subject BPCAL to licensing or other requirements within such jurisdiction.
Please contact BPCAL in Singapore in respect of any matters arising from, or in connection with this document.